期刊文献+

光滑假丝酵母菌基因分型和耐药性分析 被引量:1

Analysis of genotypes and antifungal resistance of Candida glabrata
下载PDF
导出
摘要 目的对上海交通大学医学院附属仁济医院2011—2012年分离的49株光滑假丝酵母菌进行基因分型,并对其耐药性进行分析,了解其耐药性与流行情况。方法基因分型采用脉冲场凝胶电泳(PFGE)技术,药敏试验采用ATB-FUNGUS药敏板条。结果经PFGE基因分型,49株光滑假丝酵母菌共分为17型,其中A型12株,B型11株,C型4株,D型、E型和F型各3株,G型和H型各2株,I^Q型各1株。49株菌对5-氟胞嘧啶和两性霉素敏感度最高,均为100%;其次是伏立康唑和氟康唑,敏感度分别为89.8%和85.7%;对伊曲康唑的敏感度最低,为40.8%。Ridit分析发现,不同基因型对相同药物的敏感度比较差异均无统计学意义(P>0.05)。结论 A型为仁济医院的主要克隆流行株。光滑假丝酵母菌对三唑类药物有较高的交叉耐药性,应引起临床高度重视。 Objective To analyse the genotypes and antifungal resistance of Candida glabrata isolated from Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine between 2011 and 2012 in order to investigate the drug resistance and epidemic situation. Methods Genotyping was conducted by pulsed-field gel electrophoresis(PFGE), and susceptibility tests were carried out with ATB-FUNGUS system. Results Forty-nine strains of Candida glabrata were divided into 17 genotypes by PFGE, including 12 strains of type A, 11 of type B, 4 of type C, 3 of type D, type E and type F each, 2 of type G and type H each, 1 of type I, type J and type K each. The rates of susceptibility to 5-fluorocytosine, amphotericin B, voriconazole, fluconazol and itraconazole were 100%, 100%, 89.8%, 85.7% and 40.8% respectively. There was no significant difference in the rates of susceptibility to the same drug among different genotypes ( P 〉 O. 05). Conclusion Type A was the major genotype of Candida glabrata in Renji Hospital. There is a high cross-resistance level in Candida glabrata to triazole drugs, which should be attached great importance.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第10期1352-1355,共4页 Journal of Shanghai Jiao tong University:Medical Science
关键词 脉冲场凝胶电泳 光滑假丝酵母菌 交叉耐药 pulsed-field gel electrophoresis Candida glabrata cross-resistance
  • 相关文献

参考文献7

  • 1Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata, an emerging oral opportunistic pathogen [J]. J Dent Res, 2007, 86 (3): 204 -215.
  • 2Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement[S]. PA:CLSI, 2012: M100 -S22.
  • 3Silva S, Negri M, Henriques M, et al. Candida glabrata, Candida parapsilosis and Candida tropical is : biology, epidemiology, pathogenicity and antifungal resistance [J]. FEMS Microbiol Rev, 2012, 36(2): 288 -305.
  • 4ichardson M, Lass-Florl C. Changing epidemiology of systemic fungal infections [J]. Clin Microbiol Infect, 2008, 14 (Suppl 4) : 5 -24.
  • 5Tortorano AM, Prigitano A, Lazzarini C, et al. A I-year prospective survey of candidemia in Italy and changing epidemiology over one decade[J]. Infection, 2013, 41(3): 655 -662.
  • 6Moretti ML, Trabasso P, Lyra L, et al. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil[J]. Med Mycol, 2013, 51(3): 225 - 230.
  • 7Marcos-Arias C, Erase E, Madariaga L, et al. In vitro activities of new triazole antifungal agents, posaconazole and voriconazole, against oral Candida isolates from patients suffering from denture stomatitis[J]. Mycopathologia, 2012,173(1): 35 -46.

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部